Travere Therapeutics Inc (TVTX)
Stock-Based Compensation
$21.79M
Quarterly · Period ending: · USD
TVTX Stock-Based Compensation
Latest reported$21.79Mperiod ending
Latest reported$21.79Mperiod ending
TVTX Quarterly Stock-Based Comp ($0.00 → $21.79M)
Quarterly stock-based compensation
High-resolution chart · PNG
TVTX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 21,788,000 | |
| 16,146,000 | |
| 11,464,000 | |
| 11,263,000 | |
| 10,649,000 | |
| 11,492,000 | |
| 9,214,000 | |
| 8,022,000 | |
| 9,919,000 | |
| 9,758,000 | |
| 8,144,000 | |
| 11,321,000 | |
| 11,310,000 | |
| 13,471,000 | |
| 9,528,000 | |
| 8,023,000 | |
| 12,637,000 | |
| 8,186,000 | |
| 8,576,000 | |
| 6,986,000 | |
| 7,296,000 | |
| 7,908,000 | |
| 6,352,000 | |
| 5,398,000 | |
| 5,954,000 | |
| 5,910,000 | |
| 4,497,000 | |
| 4,316,000 | |
| 6,021,000 | |
| 6,271,000 | |
| 4,660,000 | |
| 4,954,000 | |
| 5,501,000 | |
| 4,659,000 | |
| 5,582,000 | |
| 6,960,000 | |
| 7,239,000 | |
| 7,093,000 | |
| 7,068,000 | |
| 7,748,000 | |
| 7,493,000 | |
| 6,793,000 | |
| 7,152,000 | |
| 8,181,000 | |
| 4,993,723 | |
| 5,573,277 | |
| 1,191,355 | |
| 4,694,475 | |
| 5,008,271 | |
| 5,006,355 | |
| -37,452 | |
| 1,383,631 | |
| 57,516 | |
| 20,833 | |
| 8,395,820 | |
| 7,027,675 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |